AIM IMMUNOTECH INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.8M | $-3.0M | $-3.3M | $-2.8M | $-3.7M | $-3.7M | $-1.8M | $-5.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | $9.0K | — | — | $10.0K | — | — | $9.0K |
| Amortization | — | $34.0K | — | — | $48.0K | — | — | $49.0K |
| Stock-Based Compensation | — | — | — | — | $60.0K | $80.0K | $80.0K | $80.0K |
| Net Cash from Operating Activities | $-4.6M | $-2.7M | $-5.1M | $-1.5M | $-2.4M | $-3.1M | $-3.0M | $-4.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-37.0K | — | — | $898.0K | — | — | $-158.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $5.6M | — | — | $660.0K | — | — | $2.8M |
| Net Change in Cash | — | $2.8M | — | — | $-803.0K | — | — | $-2.1M |
| Free Cash Flow | — | — | — | — | — | — | — | — |